To begin to investigate the molecular mechanism underlying the synergistic antileukemic interactions between AZ20 and cytarabine in AML cells, we treated AML cell lines with both drugs alone or in combination and determined the effects on CDK1. This evidence concerns the gene CDK1 and acute myeloid leukemia.